Pericardial diseases encompass a spectrum from acute pericarditis and pericardial effusion to recurrent and constrictive forms, each requiring nuanced diagnostic and therapeutic approaches. Initial ...
A new study shows children and young people face long-lasting and higher risks of rare heart and inflammatory complications after COVID-19 infection, compared to before or without an infection.
PERICARDIAL inflammation is a relatively common complication of uremia. Although its occurrence seems superficially related to the degree of renal failure the pathogenesis is still obscure. The ...
This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being. This Scientific Reports Collection welcomes original research on Pericardial disease. Narrative review ...
A recent cross-sectional study published in the Indian Journal of Radiology and Imaging in July 2025 establishes a new diagnostic frontier for cardiac risk assessment. Researchers discovered ...
Kiniksa Pharmaceuticals is anchored by Arcalyst, the only FDA-approved therapy for recurrent pericarditis, driving robust ...
Common causes of constrictive pericarditis include prior heart surgery, a history of radiation therapy, infections such as tuberculosis, chest injury, and other possible factors. Constrictive ...
A 58-year-old woman presents to the hospital reporting fatigue, swelling of the legs and feet, and shortness of breath. She explains that her symptoms have been getting worse over the past 2 months.
DUBLIN, Feb. 27, 2019 /PRNewswire/ -- The "Recurrent Pericarditis - Market Insights, Epidemiology and Market Forecast-2028" drug pipelines has been added to ResearchAndMarkets.com's offering.
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic therapies for heart disease, today ...
Pericarditis often causes sudden chest pain that is sharp or stabbing. It can be mistaken for a heart attack. It also can mimic a lung condition. Carly Pearce vividly remembers the intense chest pain.
A comprehensive review and meta-analysis of published research confirm that young adults (40 years old and younger) have a slightly elevated risk for myocarditis or pericarditis after mRNA COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results